![](https://webarchive.library.unt.edu/eot2008/20081102203253im_/http://www.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081102203253im_/http://www.nci.nih.gov/images/spacer.gif)
| A substance that combines a monoclonal antibody (huN901) with an anticancer drug (DM1), and is being studied in the treatment of certain cancers, including non-small cell lung cancer. Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells. |
Previous Definitions: | batracylin, BAY 12-9566, BAY 43-9006, BAY 56-3722, BAY 59-8862 | Next Definitions: | BBBD, BBIC, BBR 2778, BBR 3464, BCG |
|
![](https://webarchive.library.unt.edu/eot2008/20081102203253im_/http://www.nci.nih.gov/images/spacer.gif) |